Low serum cholesterol levels predict inferior prognosis and improve NCCN‐IPI scoring in diffuse large B cell lymphoma - Gao, Rui; Liang, Jin‐Hua; Wang, Li; Zhu, Hua‐Yuan; Wu, Wei; Cao, Lei; Fan, Lei; Li, Jian‐Yong; Yang, Tao; Xu, Wei (International journal of cancer, 2018)
Keywords: Antineoplastic Agents - therapeutic use; B-cell lymphoma; Cancer; Cholesterol; Cholesterol - blood; Diagnosis; diffuse large B cell lymphoma; Disease-Free Survival; Female; High density lipoprotein; high‐density lipoprotein cholesterol; Humans; Kaplan-Meier Estimate; Low density lipoprotein; low‐density lipoprotein cholesterol; Lymphocytes B; Lymphoma; Lymphoma, Large B-Cell, Diffuse - blood; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - pathology; Male; Medical prognosis; Medical research; Middle Aged; Monoclonal antibodies; Multivariate Analysis; NCCN‐IPI; Prognosis; Remission; Retrospective Studies; Rituximab; Rituximab - therapeutic use; Targeted cancer therapy; diffuse large B cell lymphoma; prognosis; low-density lipoprotein cholesterol; NCCN-IPI; high-density lipoprotein cholesterol